Exagen Announces Campaign for Lupus Awareness Month

02 May 2023 | Tuesday | News

Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a campaign focusing on providers, patients and partnership activities that enhance the impactful work being done to help those suffering from Systemic Lupus Erythematosus (SLE).
Image Source | Public Domain

Image Source | Public Domain

Lupus Awareness Month occurs every May and is an opportunity for lupus-focused organizations to take intentional steps in creating awareness around lupus and those impacted. Lupus is a disease that AVISE® testing is specially equipped to help with and today marks the start of a month-long campaign around Bringing Awareness to Lupus Symptoms.

To deliver on this campaign, Exagen will be focusing on:

  1. A partnership with Lupus Foundation of America, providing patient educational materials to rheumatologists that showcase the importance of identifying common signs of lupus, getting a diagnosis and resources for help.
  2. Patient advocates sharing their personal journey to diagnosis and the impact of repeat testing and multiple doctor visits.
  3. Educational content shared through multiple mediums to bring awareness to lupus symptoms and its effect on the body.

This campaign will run from May 1st through the end of the month.

“Receiving a diagnosis is a central part of the journey for patients dealing with autoimmune diseases. Our mission is to shorten the time to diagnosis, empowering providers and their patients to change the trajectory of their health, especially for those dealing with lupus. Spreading awareness is key and we are proud to work with our partners to cultivate that awareness,” said John Aballi, President and CEO of Exagen.

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close